Curaleaf Holdings, Inc. announced that it has received its hybrid producer license from Connecticut's Department of Consumer Protection to supply cannabis to the state's adult-use market, which launches in June 10, 2023. Beginning at 10:00 a.m. ET on January 10, 2023, consumers over the age of 21 can purchase Curaleaf products in dispensaries approved for adult use sales across the state. The locations are Affinity Health & Wellness in New Haven, Rise in Branford, The Botanist in Montville, Fine Fettle in Newington, Stamford and Willimantic, and Willow Brook Wellness by Zen Leaf in Meriden.

Products will vary by dispensary and include Curaleaf whole flower, pre-rolls, Select Elite vapes, and Curaleaf's breakthrough vape hardware, Cliq by Select. Curaleaf team members will participate in onsite event activations and celebrations at each of the approved adult-use dispensaries on January 10, 2023. Curaleaf serves patients at its four Connecticut dispensaries in Stamford, Hartford, Milford and Groton, and anticipates welcoming adult-use customers in the near future, pending regulatory approvals.

Curaleaf will continue to prioritize patient care for individuals registered in the state's medical marijuana program during this period of expansion. Connecticut is now one of 21 states to legalize adult-use cannabis sales in the U.S. The state is expected to generate over $215 million in revenue in the first year of adult-use sales.